Skip to main content
Journal cover image

US Black cisgender women and pre-exposure prophylaxis for human immunodeficiency virus prevention: A scoping review.

Publication ,  Journal Article
Conley, C; Johnson, R; Bond, K; Brem, S; Salas, J; Randolph, S
Published in: Women's health (London, England)
January 2022

Black cisgender women in the United States experience a disproportionate burden of human immunodeficiency virus acquisition. Pre-exposure prophylaxis is an effective oral daily medication that reduces the risk of human immunodeficiency virus through sex by 99% when taken as prescribed. However, less than 2% of eligible Black cisgender women take pre-exposure prophylaxis. The purpose of this scoping review was to describe the types of research studies done in this area, gaps in knowledge, and potential areas of research needed to increase pre-exposure prophylaxis use among Black cisgender women in the United States.We conducted our search in MEDLINE (PubMed), Embase (Elsevier), CINAHL (EBSCOhost), PsycINFO (EBSCOhost), and Scopus (Elsevier) using a combination of keywords and database-specific subject headings for the following concepts: pre-exposure prophylaxis, African American/Black or minority, and women. We used the Joanna Briggs Institute's Reviewers' Manual process for Scoping Reviews and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews to ensure comprehensive and standardized reporting of each part of the review.Fifty-nine studies were included in the final review. Results of the study were classified according to the three phases of the Human Immunodeficiency Virus Prevention Cascade-demand side, supply side, and adherence and retention. The majority of studies (n = 24, 41%) were cross-sectional quantitative surveys and 43 (34%) focused on the demand-side phase of the Human Immunodeficiency Virus Prevention Cascade. Fifty-eight percent of studies either assessed women's pre-exposure prophylaxis knowledge, attitudes, and intentions to use, or assessed perceived barriers and facilitators. Seven studies (12%) tested pre-exposure prophylaxis uptake and adherence among Black cisgender women.This review found multiple missed opportunities to increase women's demand for pre-exposure prophylaxis and health care provider screening and referral for pre-exposure prophylaxis. Additional studies are needed to effectively assess pre-exposure prophylaxis uptake and adherence among Black cisgender women.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Women's health (London, England)

DOI

EISSN

1745-5065

ISSN

1745-5057

Publication Date

January 2022

Volume

18

Start / End Page

17455057221103098

Related Subject Headings

  • United States
  • Pre-Exposure Prophylaxis
  • Obstetrics & Reproductive Medicine
  • Humans
  • Health Personnel
  • HIV Infections
  • HIV
  • Female
  • Black People
  • 4206 Public health
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Conley, C., Johnson, R., Bond, K., Brem, S., Salas, J., & Randolph, S. (2022). US Black cisgender women and pre-exposure prophylaxis for human immunodeficiency virus prevention: A scoping review. Women’s Health (London, England), 18, 17455057221103098. https://doi.org/10.1177/17455057221103098
Conley, Cherie, Ragan Johnson, Keosha Bond, Sullivan Brem, Jasmine Salas, and Schenita Randolph. “US Black cisgender women and pre-exposure prophylaxis for human immunodeficiency virus prevention: A scoping review.Women’s Health (London, England) 18 (January 2022): 17455057221103098. https://doi.org/10.1177/17455057221103098.
Conley C, Johnson R, Bond K, Brem S, Salas J, Randolph S. US Black cisgender women and pre-exposure prophylaxis for human immunodeficiency virus prevention: A scoping review. Women’s health (London, England). 2022 Jan;18:17455057221103098.
Conley, Cherie, et al. “US Black cisgender women and pre-exposure prophylaxis for human immunodeficiency virus prevention: A scoping review.Women’s Health (London, England), vol. 18, Jan. 2022, p. 17455057221103098. Epmc, doi:10.1177/17455057221103098.
Conley C, Johnson R, Bond K, Brem S, Salas J, Randolph S. US Black cisgender women and pre-exposure prophylaxis for human immunodeficiency virus prevention: A scoping review. Women’s health (London, England). 2022 Jan;18:17455057221103098.
Journal cover image

Published In

Women's health (London, England)

DOI

EISSN

1745-5065

ISSN

1745-5057

Publication Date

January 2022

Volume

18

Start / End Page

17455057221103098

Related Subject Headings

  • United States
  • Pre-Exposure Prophylaxis
  • Obstetrics & Reproductive Medicine
  • Humans
  • Health Personnel
  • HIV Infections
  • HIV
  • Female
  • Black People
  • 4206 Public health